Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion (NASDAQ:OM)
Outset MedicalOutset Medical(US:OM) Seeking Alpha·2026-02-12 00:15

Group 1 - The article does not provide any specific content related to company or industry analysis [1]

Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion (NASDAQ:OM) - Reportify